Post
Everest inches towards clinical studies for renal disease drug in China
Everest Medicines is on track to commence clinical trials in China for its renal disease drug candidate, following the acceptance …
Daré Bioscience launches Phase III hormone-free contraceptive trial
US biopharma firm Daré Bioscience has started a Phase III trial investigating the effectiveness and safety of Ovaprene, a hormone-free …
Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug
Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …
Palvella and Ligand partner for Phase III rare lymphatic tumour trial
Palvella Therapeutics has partnered with Ligand Pharmaceuticals for the Phase III clinical trial investigating topical Qtorin rapamycin for the treatment …
Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study
Pharmaceutical company, Qnovia has shared positive results from initial clinical trials of its prescription inhaled smoking cessation therapy. The drug delivery …
Game changing: How AI and automation is revolutionising clinical trial admin
In the wake of COVID-19, clinical trials deserve our attention more than ever. If there’s one thing to be learned …
Clinical Trials Arena Review 2023
The year 2023 has seen the first CRISPR therapy indicate it could be …
Gain Therapeutics publishes preclinical data for GM1 gangliosidosis treatment
US-based biotechnology company Gain Therapeutics has published preclinical data demonstrating the potential of small molecule allosteric regulators to treat beta-galactosidase-1 …
Bioxodes enrols first patient in Phase IIa ischemic stroke trial
Belgium-based Bioxodes has enrolled the first patient in its Phase IIa study investigating a pipeline candidate Ir-CPI for ischemic stroke. Speaking …
Valneva reports latest findings from chikungunya vaccine trial
Valneva has reported the latest positive antibody persistence data from its Study VLA1553-303 of a single dose of chikungunya vaccine, …
AstraZeneca to halt Phase III hyperkalaemia trials of Lokelma
AstraZeneca has announced plans for the discontinuation of two Phase III clinical trials of Lokelma (sodium zirconium cyclosilicate) being analysed …
Lack of women’s data is causing femtech start ups to lose out on VC funding
The length of time needed for femtech startups to conduct studies to support their technologies is deterring venture capital (VC) …
Australian HREC approves Neurotech’s autism trial expansion
The Australian Human Research Ethics Committee (HREC) has approved Neurotech International's expansion of its ongoing Phase II/III clinical trial of …
280Bio doses first subject in oral RAS signalling inhibitor trial
280Bio has dosed the first subject in a Phase I clinical study of oral pan-RAS inhibitor, TEB-17231 (YL-17231), to treat …
Pfizer’s weight loss drug hits primary endpoint in Phase IIb trial
Pfizer has announced that its Phase IIb trial investigating oral weight loss drug danuglipron has met its primary endpoint. The glucagon-like …